ArticleCancer science2020

Dual TTK/CLK2 inhibitor, CC-671, selectively antagonizes ABCG2-mediated multidrug resistance in lung cancer cells.

Zhuo-Xun Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.